EcoDrugPlus

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSBTAG00000014335
Gene Symbol: CYP17A1
6 Enzyme and pathways 5 Cross references
217 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSBTAG00000049558
Gene Symbol: CYP17A1
6 Enzyme and pathways 4 Cross references
218 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSBTAG00000014890
Gene Symbol: CYP19A1
9 Enzyme and pathways 5 Cross references
350 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSBTAG00000021118
Gene Symbol: CYP26A1
9 Enzyme and pathways 5 Cross references
220 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 24

Ensembl ID : ENSBTAG00000054260
Gene Symbol: CYP3A24
7 Enzyme and pathways 5 Cross references
735 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 28

Ensembl ID : ENSBTAG00000049666
Gene Symbol: CYP3A28
7 Enzyme and pathways 5 Cross references
733 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 74

Ensembl ID : ENSBTAG00000052665
Gene Symbol: CYP3A74
16 Enzyme and pathways 5 Cross references
731 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 76

Ensembl ID : ENSBTAG00000053645
Gene Symbol: CYP3A76
7 Enzyme and pathways 5 Cross references
737 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSBTAG00000035544
Gene Symbol: CYP46A1
10 Enzyme and pathways 5 Cross references
272 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSBTAG00000026356
Gene Symbol: DGAT1
10 Enzyme and pathways 5 Cross references
274 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSBTAG00000007681
Gene Symbol: DHFR
4 Enzyme and pathways 4 Cross references
360 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSBTAG00000019887
Gene Symbol: DHODH
4 Enzyme and pathways 4 Cross references
185 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).